Objective: To evaluate the effects of gemfibrozil upon the intravascular metabolism of chylomicron-like emulsions in endogenous hypertriglyceridemia. Methods: We evaluated the plasma kinetics of a chylomicron-like emulsion in 39 subjects: 27 hypertriglyceridemics, total cholesterol (TC) expressed as median (%25; %75) 7.47 (6.1; 8.19) mmol / l and plasma triglycerides (TG) 4.28 (3.6; 18.5) mmol / l and in 12 normolipidemics, TC 4.7 (3.85; 5.37) mmol / l and TG 0.91 (0.64; 1.75) mmol / l. Hypertriglyceridemics were evaluated 14 at baseline and after a 30-day 1200-mg / day gemfibrozil (n58) or placebo treatment (n57). The emulsion labelled with C-cholesteryl emic patients reduced the residence times of H-TO and C-CO, respectively, by 46% (P50.003) and 53% (P50.008). Effects were noted on the slow phase of emulsion plasma removal, which was reduced in hypertriglyceridemics. After treatment, the emulsion residence times determined in hypertriglyceridemics attained the values of the normolipidemic group. Conclusions: Gemfibrozil treatment normalised the defects in chylomicron-like emulsion catabolism observed in endogenous hypertriglyceridemia patients.
Introduction
removes not only LDL and VLDL remnants but is mainly responsible for the clearance from the plasma of chylomicBoth triglyceride-rich lipoproteins, chylomicrons origiron remnants [4, 5] . nated in the intestine, and liver-synthesised VLDL, share VLDL is routinely evaluated by measuring the concommon intravascular catabolic pathways [1] [2] [3] [4] . Both centration of fasting plasma triglycerides. On the other undergo lipolysis by lipoprotein lipase stimulated by hand, due to technical difficulties, the status of chylomicapolipoprotein (Apo) CII on the endothelium surface of ron metabolism in man is much less studied. capillary vessels. Efficient degradation of VLDL and It has been shown that entry of chylomicrons into the chylomicrons is necessary for their optimal clearance from bloodstream elicits accumulation in the plasma of VLDL plasma. It has been suggested that the LDL receptor [2, 6] . This occurs because the presence in the circulation of a large concentration of chylomicrons saturates the lipolytic mechanism and perhaps the removal mechanismś* versely, it is worthwhile to verify whether VLDL accumuenrolment in the study, uncontrolled diabetes mellitus, e.g. lation in the plasma also results in decreased removal of fasting blood glucose $7.5 mmol / l (135 mg / dl) or chylomicrons. Since fasting hypertriglyceridemia may glycated hemoglobin .7.5% [19] , use of ethanol, presence involve defects in VLDL synthesis and catabolism the of heart failure, hepatic, renal or thyroid disease, women question is whether those defects would also lead to slow within reproductive age without the use of a mechanical chylomicron catabolism and remnant removal. In fact, this contraceptive method, use of hormones, uncontrolled issue has been addressed in studies that used fat tolerance clinical diseases other than hyperlipidemia, acute coronary tests with ingestion of vitamin A as chylomicron marker or cerebrovascular event within the last 6 months, and any [7] [8] [9] . After the ingestion of the standard fatty meal, collateral effect or previous intolerance to gemfibrozil. subjects with fasting hypertriglyceridemia have diminished
Patients were compared to non-diabetic normolipidemic vitamin A elimination from the plasma and higher postsubjects, TG ,2.26 mmol / l (200 mg / dl), TC ,6.2 mmol / prandial triglyceridemia [7, 9] . l (240 mg / dl), and LDL-C ,4.1 mmol / l (160 mg / dl) Chylomicron-like lipid emulsions are a practical and presenting none of the exclusion criteria previously cited. direct approach to evaluate chylomicron metabolism [10] [11] [12] [13] [14] [15] . After injection into the plasma, these emulsions that 2.2. Study design are devoid of proteins, adsorb Apo CII and Apo E and other apolipoproteins that mediate this metabolism [10, 11] .
This project was conducted in two parts. Firstly, the Thus, similarly to the processes lymph chylomicrons emulsion kinetics of 27 hypertriglyceridemic patients were undergo when entering blood stream, emulsion tricompared with those of the 12 normolipidemic controls. glycerides are hydrolysed by lipoprotein lipase and the Secondly, the emulsion kinetics were evaluated in 15 resulting remnants bind to receptors that remove chylomicconsecutive hyperlipidemics who were randomised to a ron remnants [11] . Emulsions can be labelled with radio-30-day 1200-mg / day gemfibrozil (Parke Davis Laborator-14  14  3 ies, Sao Paulo, Brazil) (n58) or equivalent placebo isotopes such as C-cholesteryl oleate ( C-CO) and H- 3 1 4 treatment (n57). This was a single blinded study, and triolein ( H-TO). The plasma kinetics of C-CO allows neither patients nor those responsible for the calculations evaluation of the removal of the emulsion particles, since were aware of the treatment status of the patients. Attendthe transfer of this label to the plasma lipoproteins is ing physicians were aware of which medication was being negligible [10, 12] . On the other hand, the kinetics of the 3 used, however they strictly followed the rules of the H-TO allows the evaluation of emulsion lipolysis [12] . randomisation sheet. The effects of gemfibrozil on emulThis model introduced by Redgrave and Maranhao [10] sion kinetics in those eight patients were also compared to has been previously validated in animals [10] [11] [12] and in the values of the 12 normolipidemic subjects. human subjects [13] [14] [15] .
This study was performed in agreement with the rules of Fibrates have been used to treat fasting hypertriglyceridthe Helsinki Conference and was approved by the Sciemia by reducing VLDL plasma levels [16] . However, the entific Committee of The Heart Institute of the Hospital effects of fibrates on chylomicron lipolysis and remnantd as Clınicas of the Sao Paulo University Medical School. removal have not yet been completely established in Informed consent was obtained from all participants. patients with endogenous hypertriglyceridemia [9, 17, 18 ]. In the current study, the intravascular metabolism of a 2.3. Laboratory evaluation chylomicron-like emulsion in hypertriglyceridemics was compared with that of normolipidemic subjects and the Plasma samples were collected after a 12-h fast on 2 effects of gemfibrozil were evaluated. Our results show consecutive days and the results were averaged. Plasma that hypertriglyceridemic patients have altered plasma total cholesterol and triglycerides were determined using kinetics of the chylomicron-like emulsion but after gemfibenzymatic methods (Roche Laboratories, Basel, Switzerrozil treatment they approach the values of normolipidemic land). HDL-cholesterol (HDL-C) was determined by the subjects.
same method as total cholesterol, after chemical precipitation of Apo B-100 containing lipoproteins with MgCl and phosphotungistic acid. LDL-cholesterol (LDL-C) was 2. Methods calculated by the subtraction of HDL-C and VLDL-cholesterol (VLDL-C) from total cholesterol. VLDL-C was 2.1. Study subjects calculated by dividing triglycerides by 5 for triglyceride levels up to 4.5 mmol / l (400 mg / dl). Apo B and Apo AI This study evaluated subjects with endogenous hypertriwere also determined by immunoturbidimetry (Roche glyceridemia with plasma triglycerides (TG) $2.26 mmol / Laboratories, Basel, Switzerland). All lipid, and apolipol (200 mg / dl) and age between 18 and 70 years. The protein determinations were performed automatically in a exclusion criteria were: type I or type V hyperlipidemia, COBAS-MIRA analyser (Roche Laboratories, Basel, use of lipid lowering drugs in the last 3 months before Switzerland).
Lipoprotein electrophoresis was performed in cellulose Roche Laboratories, Sao Paulo, Brazil) and was immediacetate, with a barbital buffer, pH 7.2, and coloured by ately centrifuged at 2700 rpm during 10 min (Sorvall Sudam black. Quantification was made by optical dencentrifuge, model RT7, Wilmington, USA). An aliquot of 1 sitometry.
ml of plasma was transferred to counting vials and 7 ml of Apo E genotyping was performed by the technique scintillation solution PPO: DM-POPOP: Triton X-100 / described by Hixson and Vermier [20] . toluene (5 g: 0.5 g: 333 ml / 667 ml) were added to the vials. Radioactivity in the samples was determined using a Packard 1660 TR spectrometer (Packard, Meridien, USA).
Emulsion preparation
The plasma decay of the radioisotopes was used to calculate the kinetics of the emulsion. Chylomicron-like emulsions were prepared as described
As The compartmental analysis was performed according to was by ultracentrifugation using discontinuous NaCl graa modification of the model proposed by Redgrave and dients with densities of 1.065, 1.020, and 1.006 g / ml and a Zech [12] . The full description of the model employed and TH 641 rotor using a Sorvall ultracentrifuge (model OTD the calculations are shown in Appendix A. In short, four Comb, Wilmington, USA) at 12,000 rpm at 228C for 15 compartments were employed to estimate the kinetic min. The coarse lipid layer that initially floated to the top 14 3 parameters for both C-CO and H-TO tracers ( represents the lipolytic mechanism and is represented by min. All plastic materials were sterilised by ultra-violet compartments 5-8. The kinetics of chylomicron-like emullight exposition. All mixing procedures were performed sion is represented by the plasma residence times exunder laminar flux. The lipid composition of the emulsion pressed in minutes of both radioisotopes and was calcuas determined by standard laboratory methods was 1.9% cholesterol, 10.4% phospholipids, 11.2% cholesteryl ester and 76.5% triacylglicerols (% weight).
Emulsion kinetic studies
All hyperlipidemic patients were following a low fat, low in simple carbohydrates diet for 30 days. During the study, patients were asked to keep to their diet and to abstain from ethanol. All kinetic studies were performed after a 12-h fast. Two veins from different arms were cannulated and kept with a saline flush. On average 100 ml 3 of the emulsion containing 148 kBq (4 mci) of H-TO and 14 74 kBq (2 mci) of C-CO were injected in a bolus followed by a 5-ml saline flush. Blood samples were collected on the contra-lateral arm vein at 2, 4, 6, 10, 15, 30, 45 and 60 min after injection. Blood was dispensed using computerised software [21] . Clinical parameters, plasma lipids and apolipoproteins of the hypertriglyceridemic patients and normolipidemic 2.7. Statistical analysis volunteers at baseline are shown in Table 1 . There were no differences between the groups regarding age, gender, Data normal distribution was tested by the Kolbody mass index, number of smokers and subjects with mogorov-Smirnov procedure. Since most parameters were arterial hypertension. There were two diabetics on treatnot normally distributed, lipid profile and kinetic data were ment in the hypertriglyceridemic group and none in the expressed as median (%25; %75) unless otherwise stated.
normolipidemic group. The number of patients using betaCategorical data were compared by Fisher's exact test.
blockers or thiazidic diuretics was also similar in the two Spearman's rank correlation was used to evaluate any groups (Table 1 ). However, in the hypertriglyceridemic 3 1 4 association between H-TO and C-CO residence times group nine (33%) of the enrolled patients had a history of with age, body mass index, total plasma cholesterol, coronary artery disease and none among normolipidemics plasma triglycerides, HDL-C, Apo AI and Apo B levels. If (P50.03). A total of 18 patients presented a type IV a correlation was detected, non-parametric data were pattern on lipid electrophoresis, eight presented type IIB normalised using logarithmic transformation and linear and one showed broad b pattern (type III) with concomiregression was used. The multiple linear regression protant Apo E2 / E2 genotype. There were no differences in cedure was used to determine if the correlation persisted the distribution of apolipoprotein E genotypes between the after adjustment for other variables. Non-paired data were normolipidemic and hypertriglyceridemic subjects ( 
Comparison of the patients randomized to gemfibrozil or placebo
The clinical and laboratory characteristics of the hypertriglyceridemic patients that received gemfibrozil or placebo are shown in Table 3 . There were no differences regarding clinical parameters and the use of thiazidic diuretics or beta-blockers. Also, total cholesterol and HDL-C levels were similar. Despite randomisation plasma triglyceride levels were higher in the group allocated to gemfibrozil (P50.001). However, there were no differences regarding the residence times of the labelled emulsion lipids at baseline (Table 3) .
Gemfibrozil treatment reduced the residence times of 3 1 4 H-TO and C-CO by, respectively, 46% (P50.003) and 53% (P50.008). There was a 92% increase in k (P5 2, 3 0.008) and a 51% increase in k (P50.008). There were 6, 7 no alterations in the rapid clearance component represented by k and k . Data are shown in Table 4 . The radio-1, 3 5,7 isotopic decaying curves before and after gemfibrozil treatment are shown in Fig. 3 . The residence times of the tracers were not affected by placebo administration, re- 14 C-CO in patients that received gemfibrozil became (P50.03), plasma triglycerides by 59% (P50.002) and similar to those of normolipidemics (Tables 2 and 4). increasing HDL-C by 25% (P50.008). These values Compared to baseline, gemfibrozil treatment improved attained after treatment with the drug were no longer plasma lipids by reducing total plasma cholesterol by 23% different of those of normolipidemics (Tables 2 and 4) . ing curves of the emulsion radiolabels assess, by analogy, chylomicron degradation and removal from the plasma.
Injected after a 12-h fast in minimal amounts the emulsion does not disturb VLDL metabolism as occurs in fat-load tests [2, 3] . The residence times of the two emulsion components injected into normolipidemic subjects calculated according to the technique described above were similar to those obtained for native chylomicrons labelled with vitamin A and reinjected into the subjects [7, 22, 23] . The type IV and IIB patients studied here showed defects in both emulsion lipolysis and removal from the plasma despite the fact that they had not displayed chylomicron accumulation after 12-h fast by lipoprotein electrophoresis. Chylomicrons and chylomicron-like emulsions are removed from plasma in a two-phase manner, reflected by the grossly bi-exponential decay curve [4,12,14,15]. Initially, there is a rapid removal accounted for by the redistribution of the injected chylomicron particles to sites where they may access such as the space of Disse and to lipolytic sites located on the endothelium, referred as chylomicron margination [24, 25] . The second (slower) removal phase depends initially on chylomicron lipolysis and generation of remnants that subsequently enter the space of Disse [4] . There, remnants can bind directly to the LDL receptor or the low density lipoprotein related protein (LRP) receptor [4, 5] , a mechanism that is dependent on Apo E, and are thus taken-up by the liver cells. According to the adopted kinetic model, the differences between hypertriglyceridemic patients and their normolipidemic controls arise in the slow phase of the decaying curve expressed by k and k . In contrast, 2,3 6,7 there were no differences between the two groups regarding k and k that represent the transference rates of the eventually be attributed to competition of the emulsion with accumulated VLDL for the common catabolic pathway [1] , because it has been shown that excess VLDL 4. Discussion reduces chylomicron clearance from plasma [9, 14] . Similarly to the post-prandial triglyceridemia curves obtained In fat load test, the area under the ascending-descending from oral fat load tests [17, 26] , the plasma kinetics of both curve of post-prandial plasma triglycerides and vitamin A emulsion labels correlated with the fast triglyceride values. supposedly represents the input and output of chylomicron This finding is important for the understanding of the lipids into the circulation [9] . However, while the absorpdifferences in emulsion kinetic data between hypertriglyction process lasts several hours, chylomicron remnants are eridemics and normolipidemics as well as the improvement rapidly taken-up by the liver and their lipids start to of emulsion clearance after gemfibrozil treatment. Howrecirculate back into the plasma compartment incorporated ever, even when multiple regression analysis was perinto newly synthesised VLDL [7, 22] . Because chylomicformed we were able to explain no more than 40% of the rons compete with VLDL for lipolysis by lipoprotein lipase radioisotope's residence time values. The intravascular [1] , accumulation of VLDL occurs in the post-prandial metabolism of the emulsion may be influenced in the same period, adding-up to the increase of post-prandial lipids manner as chylomicrons by factors such as apolipoprotein [2, 3] . Therefore, the area under the curve of post-prandial E genotype [27] , lipoprotein and hepatic lipase activities plasma triglycerides and vitamin A represents the summa- [10, 26] , and insulin plasma levels [28] . In this respect, in tion of complex phenomena and is thus difficult to our study, differences in emulsion kinetic data between interpret. In contrast, the labelled chylomicron-like emulnormolipidemics and hypertriglyceridemics cannot be assions are injected intravenously in a bolus [11, 15] . The cribed to Apo E genotypes, because their frequency was gastrointestinal component is thus bypassed and the decaysimilar in the two groups. 29] . The reduction of expression of Apo C-III, which is a lipoprotein lipase As previously described [12] , the kinetic model used in inhibitor, is accounted for by the increased activity of this this study agrees with the fitting of experimental curve enzyme [16] . However, decreased VLDL synthesis inwhich shows the following profile: both radioactivity duced by this drug would lead to a reduced competition 14 3 decay curves ( C-CO and H-TO) show a rapid decay between emulsion and lipoproteins for lipolytic sites, as followed by a slow decay and finally the curve tends to a well as for Apo C-II and Apo E binding. The reduction of plateau or to a smooth increase suggesting recycling of the Apo C-III levels may also facilitate binding to receptors radioactivity compounds incorporated into VLDL secreted since this lipoprotein reduces the Apo E-dependent clearby the liver. These features are similar to the biphasic ance [30] . We also cannot discard stimulatory effects of plasma decay curve of natural chylomicrons [4] . Compartgemfibrozil on hepatic lipase [31] and on LDL receptor ment 1 ( Fig. 1 ) corresponds to the chylomicron-like expression [32] , both factors that increase remnant clear- consider a direct output from compartment 1 but the removal. Attia et al. [18] showed that bezafibrate use led to absence of a plateau at the beginning of the decaying curve slow remnant removal in diabetic patients with very high as previously shown [13] [14] [15] suggests that a fraction of the triglyceride levels. It remains undefined whether those injected particles, denominated k in our study is directly 1, 3 findings are consequent to differences in the used drugs or removed from the plasma by the liver or other tissues thus in the studied patient groups or, else, to limitations of the bypassing the delay time demanded by compartment 2. vitamin A test.
After removal from plasma, lipids from compartments 1 Evaluated by either fat load tests [34] [35] [36] reducing HDL-C levels [38, 39] , remains to be settled. and peripheral tissues). Recirculation of H-TO was also There is evidence that fibrates may reduce atherosclerosis considered in the form of VLDL secretion (compartment clearance by use of gemfibrozil, as in the case of our study assumed to represent the combination of the transference evaluated by a chylomicron-like emulsion may have rate of the remnant particle (k ) and removal from plasma 2, 3 3 potential anti-atherogenic mechanisms.
of the H-free fatty acid. In order to achieve more accurate parameters, the curve 14 fitting was done by pooling the data from C-CO and 3
